PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research
Globenewswire·2026-01-08 13:30
TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has executed an agreement with Østfold Hospital Trust of Norway. “It was gratifying to be selected as the supplier to Østfold Hospital Trust following a lengthy diligence and negotiation process comple ...